Arrowstreet Capital, Limited Partnership Spectrum Pharmaceuticals Inc Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.65 - $1.31 $27,425 - $55,272	42,193 New	42,193 $41,000
Q2 2018 Aug 14, 2018	SELL	$14.31 - $21.75 $937,705 - $1.43 Million	-65,528 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$16.09 - $23.07 $1.05 Million - $1.51 Million	65,528 New	65,528 $1.05 Million
Q4 2017 Feb 09, 2018	SELL	$13.36 - $20.73 $363,392 - $563,856	-27,200 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.75 - $14.07 $238,000 - $382,704	27,200	27,200 $383,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.